Acumen Pharmaceuticals, Inc.
Support and Resistance Levels
Past performance
News About ABOS
All events for ABOS
All deals for ABOS
Financial Ratios
Financial Statements
ABOS vs Sector & Peers
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia. Website acumenpharm.com
Headquarters Newton, MA, US